The wrist wearable promises continuous tracking and real-time estrogen and progesterone insights
Posted:
Women’s health startup Clair has unveiled a wrist-worn wearable that tracks four key reproductive hormones without requiring blood or urine samples.
These include estrogen, progesterone, luteinising hormone (LH), and follicle-stimulating hormone (FSH), without the need for invasive blood draws or urine tests.
New York-based Claryx has emerged from stealth with $3.5 million in pre-seed funding.
Outlander VC led the round, with participation from Company Ventures, Boost VC, Neon, Mana Ventures, 640 Oxford and Precursor Ventures.
The funding will help Claryx continue to "build…
Researchers have shown that measurements taken from a person's fingertip could help identify physical patterns associated with stress, anxiety and depression.
The international study, involving experts from Aston University, used a wearable device that shines light into the skin to…
Attendees
Sponsors and Exhibitors
Contact us